iifl-logo

Most Read News

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Alkem Laboratories Ltd is quoting at Rs 3331.4, up 0.94% on the day as on 12:49 IST on the NSE. The stock is up 20.12% in last one year as compared to a 10.75% spurt in NIFTY and a 9.93% spurt in the Nifty Pharma.

image

To be marketed by Strides Pharma Inc. in the US market.

image

At meeting held on 11 March 2022

image

Firstsource Solutions has allotted 16,185 equity shares under ESOS on 09 March 2022. Powered by Capital Market – Live News

image

NHPC, Indias premier hydropower company and a Mini Ratna Category-I Enterprise of the Government of India has paid an interim dividend of Rs. 933.61 crore to Government of India for the financial year 2021-22 on 04 March 2022. NHPC had already paid Rs. 249.44 crore to Government of India during the current fiscal 2021-22 on account of final dividend for the financial year 2020-21. Thus, […]

image

Glenmark Pharmaceuticals Ltd is quoting at Rs 453.05, up 1.68% on the day as on 12:49 IST on the NSE. The stock is down 5.37% in last one year as compared to a 10.75% jump in NIFTY and a 9.93% jump in the Nifty Pharma.

image

The company established its diagnostics business in Kolkata.

image

APL Apollo Tubes has allotted 1,75,000 equity shares under ESOS. Consequently, the paid-up equity share capital of the company stands increased from to Rs 50,05,61,000/- comprising 25,02,80,500 equity shares of Rs 2/- each. Powered by Capital Market – Live News

image

Biocon announced that ICRA has placed its ICRA AA+ and ICRA A1+ ratings on the long term and short-term banking facilities of the Company on Watch with Developing Implications. Powered by Capital Market – Live News

Image
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.